 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
With Navigenics Purchase, LifeTech Speeds Entry into Molecular Diagnostics Space
July 18, 2012
With Navigenics Purchase, LifeTech Speeds Entry into Molecular Diagnostics Space
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Life Tech to Market Dx Version of QuantStudio Platform; Developing Assays with Quidel
July 26, 2012 / PCR Insider - Following CLIA Lab Buy, Life Tech Jumps into MDx Space with Purchase of Pinpoint, Lung Cancer Dx
July 25, 2012 / Pharmacogenomics Reporter - Life Tech to Follow Navigenics Buy With More Acquisitions as it Builds MDx Portfolio
July 18, 2012 / GenomeWeb Daily News - Navigenics Outlines Focus on Corporate Wellness Programs to Sell its Genomic Screening Services
January 26, 2011 / Pharmacogenomics Reporter - Navigenics Launches Cheaper Annual Genomic Service; Will Doctors Bite?
February 4, 2009 / Pharmacogenomics Reporter